By otakuyassine3@gmail.com 
BSW Wealth Partners increased its stake in Agilent Technologies, Inc. (NYSE:A – Free Report) by 8.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,343 shares of the medical research company’s stock after purchasing an additional 403 shares during the period. BSW Wealth Partners’ holdings in Agilent Technologies were worth $718,000 as of its most recent SEC filing.
Other large investors have also recently bought and sold shares of the company. Livelsberger Financial Advisory acquired a new stake in Agilent Technologies in the third quarter worth $28,000. CKW Financial Group grew its position in shares of Agilent Technologies by 114.9% in the 4th quarter. CKW Financial Group now owns 187 shares of the medical research company’s stock valued at $25,000 after purchasing an additional 100 shares during the period. Ashton Thomas Securities LLC bought a new stake in Agilent Technologies during the 3rd quarter worth approximately $31,000. Fortitude Family Office LLC boosted its holdings in shares of Agilent Technologies by 68.3% in the third quarter. Fortitude Family Office LLC now owns 234 shares of the medical research company’s stock valued at $35,000 after buying an additional 95 shares during the period. Finally, RPg Family Wealth Advisory LLC bought a new stake in Agilent Technologies in the 3rd quarter valued at $38,000.
Insider Activity
In related news, CEO Padraig Mcdonnell sold 1,911 shares of the firm’s stock in a transaction dated Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total value of $286,650.00. Following the sale, the chief executive officer now directly owns 39,652 shares of the company’s stock, valued at $5,947,800. This trade represents a 4.60 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link.
Agilent Technologies Price Performance
Shares of NYSE A opened at $150.35 on Wednesday. The business’s 50 day moving average is $138.91 and its 200-day moving average is $138.37. The firm has a market cap of $42.94 billion, a P/E ratio of 34.02, a price-to-earnings-growth ratio of 4.12 and a beta of 1.06. Agilent Technologies, Inc. has a 1-year low of $124.16 and a 1-year high of $155.35. The company has a current ratio of 2.09, a quick ratio of 1.58 and a debt-to-equity ratio of 0.57.
Agilent Technologies (NYSE:A – Get Free Report) last released its quarterly earnings results on Monday, November 25th. The medical research company reported $1.46 EPS for the quarter, topping analysts’ consensus estimates of $1.41 by $0.05. Agilent Technologies had a net margin of 19.80% and a return on equity of 25.43%. The business had revenue of $1.70 billion for the quarter, compared to analyst estimates of $1.67 billion. During the same period last year, the firm earned $1.38 earnings per share. Agilent Technologies’s revenue for the quarter was up .8% compared to the same quarter last year. Equities research analysts predict that Agilent Technologies, Inc. will post 5.56 earnings per share for the current year.
Agilent Technologies Increases Dividend
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, January 22nd. Shareholders of record on Tuesday, December 31st were issued a $0.248 dividend. The ex-dividend date was Tuesday, December 31st. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.24. This represents a $0.99 annualized dividend and a yield of 0.66%. Agilent Technologies’s payout ratio is currently 22.40%.
Wall Street Analyst Weigh In
A has been the topic of several recent research reports. Bank of America dropped their price target on Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating on the stock in a research note on Friday, December 13th. StockNews.com raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Tuesday, December 24th. Citigroup boosted their price target on shares of Agilent Technologies to $165.00 and gave the stock a “buy” rating in a research report on Thursday, December 19th. Evercore ISI lifted their target price on Agilent Technologies from $135.00 to $145.00 and gave the company an “in-line” rating in a research report on Tuesday, October 1st. Finally, Sanford C. Bernstein decreased their price target on Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating for the company in a research note on Tuesday, November 26th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and eight have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $143.62.
Check Out Our Latest Report on A
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
Featured Articles
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Free Report).
Receive News & Ratings for Agilent Technologies Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Agilent Technologies and related companies with MarketBeat.com’s FREE daily email newsletter.